Sources: Pickart & Margolina, Int J Mol Sci 2018 (PMID: 29986520) | Pickart et al., BioMed Res Int 2015 (PMID: 26236449) Security Profile & Chemical Identity Molecular specifications and documented tolerance in clinical studies GHK-Cu Chemical Identity Natural copper complex of the tripeptide glycyl-L-histidyl-L-lysine GHK-Cu Tolerance & Status Safety data from clinical and cosmetic studies Published Clinical & Preclinical Data Key studies published in Int J Mol Sci, BioMed Res Int and dermatological journals -55.8% Reduction in wrinkle volume after 12 weeks of topical application of GHK-Cu cream Anti-Aging Results (12 weeks) 4 000+ Human genes modulated by GHK-Cu (31.2% of the genome) Genomic Impact + 70 % Increased collagen synthesis in human skin fibroblasts Collagen Stimulation Comparison Published Clinical & Preclinical Data Key studies published in Int J Mol Sci, BioMed Res Int and dermatological journals -55.8% Reduction in wrinkle volume after 12 weeks of topical application of GHK-Cu cream Anti-Aging Results (12 weeks) 4 000+ Human genes modulated by GHK-Cu (31.2% of the genome) Genomic Impact + 70 % Increased collagen synthesis in human skin fibroblasts Collagen Stimulation Comparison Important Notice Search Only Not intended for human consumption

While a low level may support the diagnosis, a normal or borderline level does not rule out deficiency
Technical Characteristics Active Substance Concentration: 50,000 ppm (5%) Copper Tripeptide-1
INCI Nomenclature: GHK-Cu (glycyl-l-histidyl-l-lysine)
For anyone considering BPC-157, sourcing from suppliers that provide certificates of analysis from accredited third-party laboratories is a necessary harm-reduction step
In addition, lorcaserin administration decreased the incidence of T2DM by 19% in patients with prediabetes and by 23% in patients without diabetes